Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Shares Issued (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 13 years of Shares Issued data on record, last reported at -$23.9 million in Q2 2025.

  • For Q2 2025, Shares Issued fell 3195.3% year-over-year to -$23.9 million; the TTM value through Feb 2025 reached $23.1 million, up 664.52%, while the annual FY2020 figure was $30000.0, 90.83% down from the prior year.
  • Shares Issued reached -$23.9 million in Q2 2025 per LFCR's latest filing, down from $17000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $23.8 million in Q4 2024 and bottomed at -$23.9 million in Q2 2025.
  • Average Shares Issued over 4 years is $0.0, with a median of $1000.0 recorded in 2024.
  • Peak YoY movement for Shares Issued: skyrocketed 506.74% in 2024, then plummeted 3195.3% in 2025.
  • A 4-year view of Shares Issued shows it stood at $5.0 million in 2022, then plummeted by 196.44% to -$4.8 million in 2023, then soared by 594.4% to $23.8 million in 2024, then plummeted by 200.08% to -$23.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were -$23.9 million in Q2 2025, $17000.0 in Q1 2025, and $23.8 million in Q4 2024.